ICODA’s partner Lowet moderates regulatory AIM panel
At AIM’s 2016 International conference, Solvency II was mentioned as the single most important regulatory development, both by small and large health mutuals alike. One panelist called the Solvency II pillar 3 reporting requirements “brutal” in terms of number of information from an SME-type of insurer. Another panelist commented on the sudden change of national legislators as to the scope of the framework.
Lowet asked the panelist what was missing in the regulatory framework. Panelist mentioned an insurance specific recovery and resolution. This would especially be important in case the dialogue with the supervisors goes wrong. Legislators could also look more beneficial to capital requirements. Panelists found the mutuals should lobby for it, and not be silent. They called to AIM and others to let the legislators know how a mutual works.
The international conference on 25 November 2016 was attended by more than 100 people with participants from Europe, Africa, and Latin America.
For more information about ICODA’s panel moderation and participation services, contact email@example.com